MedTrace Logo

Dose Defining Study for the Administration of Vitamin K2 Supplements in Hemodialysis Patients

NCT01675206 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2012-08-29

No results posted yet for this study

Summary

This study aims at finding the optimal dose of Vitamin K2 supplementation in hemodialysis patients.

Conditions

  • Vascular Calcification

Interventions

DIETARY_SUPPLEMENT

Vitamin K2 supplementation

Sponsors & Collaborators

  • Rogier Caluwe

    lead OTHER

Principal Investigators

  • Rogier Caluwé, MD · OLV Hospital Aalst Belgium

  • Bruno Van Vlem, MD, PhD · OLV Hospital Aalst Belgium

  • An Devriese, MD, PhD · AZ St.-Jan Brugge Belgium

  • Stefaan Vandecasteele, MD, PhD · AZ St.-Jan Brugge Belgium

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2011-09-30
Completion
2012-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01675206 on ClinicalTrials.gov